Stay updated on ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the expected study details and navigation. This indicates the page is currently inaccessible due to access restrictions or server configuration.
    Difference
    17%
    Check dated 2026-09-21T22:21:01.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.6) indicating a new build or patch, but the study details and visible content remain unchanged.
    Difference
    0.1%
    Check dated 2026-08-31T17:19:52.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page now includes the full study details with attached documents (Study Protocol and Statistical Analysis Plan) and expanded metadata. The previous error page content has been removed, restoring access to the study record.
    Difference
    41%
    Check dated 2026-08-17T07:51:13.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.4 to v3.6.5, indicating a newer build of the site template and assets.
    Difference
    0.1%
    Check dated 2026-08-10T01:12:42.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page displays Revision: v3.6.4, replacing the previous v3.6.3, signaling a platform update to the site interface.
    Difference
    0.1%
    Check dated 2026-07-26T14:22:17.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The revision label was updated from v3.6.2 to v3.6.3, indicating a maintenance release rather than substantive changes to study information.
    Difference
    0.1%
    Check dated 2026-07-05T04:31:16.000Z thumbnail image

Stay in the know with updates to ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.